Parkinson's Disease clinical trials
Showing 251–300 of 314 active trials. Describe your situation to see which ones look like a fit.
- Longitudinal Natural History Protocol for PRKN- and PINK1-Linked PD
- Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
- Remote Monitoring in Progressive Supranuclear Palsy (PSP)
- Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease
- Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease
- Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease
- Gamification and Physical Activity in PD
- Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
- Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD)
- Deep Brain Stimulation (DBS) of the Pedunculopontine Nucleus (PPN)
- NAD Supplementation in Parkinson's Disease
- Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease
- Long Term Follow Up KET-PD
- CS1P1 PET Studies of Neuroinflammation in Parkinson Disease
- Exercise Strategies in Parkinson's Disease
- A High-density Microelectrode for Human Neuronal Recordings
- Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
- An Observational Study of Patients With Moderate Parkinson's Disease
- Vibrotactile Coordinated Reset for the Treatment of Advanced Parkinson's Disease
- DBS Recordings to Characterize Movement Facilitation in Parkinson's Disease
- Closed Loop DBS Implanted RC+S Study
- Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core
- Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy
- Movement State-dependent Adaptive DBS for PD
- Radiation Therapy (RT) for Parkinson's Disease (PD)
- Understanding Freezing of Gait Using Brain Signals and Virtual Reality
- AB-1005 Long-Term Follow-up Study
- TMS in Anxiety-Parkinson's Disease
- LFP Sensing From Directional Leads in the Acute Clinical Setting
- Adaptive Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease
- Cognitive Effects of Exercise in Parkinson's Disease
- Intracranial Recordings to Characterize Action Regulation Mechanisms
- Connectomic Guided DBS for Parkinson's Disease
- Quantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to Treatment
- Lithium for Parkinson's: an Extension Trial
- Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
- Phase 1/2a Study of ANPD001 in Parkinson Disease
- Effects of Stimulation Patterns of Deep Brain Stimulation
- Genetic Studies of Lysosomal Storage Disorders
- Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
- Quality Improvement and Practice Based Research in Neurology Using the EMR
- Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research
- DaTSCAN Imaging in Aging and Neurodegenerative Disease
- Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
- Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
- Mid-frontal Delta/Theta and Cognitive Control
- Quest to Analyze One Thousand Humans Meditating
- North American Prodromal Synucleinopathy Consortium Stage 2
- Relative Bioavailability Study of HNC364 Injectable Suspension
- Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.